Patient Alerts has developed a PHQ-2 Screening Tool to be used in a Clinical System.
The PHQ-2 inquires about the frequency of depressed mood and anhedonia over the past two weeks.
The purpose of the PHQ-2 is not to establish final a diagnosis or to monitor depression severity, but rather to screen for depression in a first step approach.
Patient Alerts has developed a PHQ-9 Screening Tool to be used in a Clinical System.
The PHQ-9 is a multipurpose instrument for screening, diagnosing, monitoring and measuring the severity of depression.
The PHQ-9 incorporates DSM-IV depression diagnostic criteria with other leading major depressive symptoms into a brief self-report tool.
Patient Alerts has developed a PHQ9A Screening Tool to be used in a Clinical System.
The patient health questionnaire is based on DSM-IV diagnostic criteria and has been validated in primary care, obstetrics and gynecological patient populations. A shorter version of the PHQ-9 is useful in research settings and is also discussed in the article.
As PHQ-9 depression severity increased, there was a substantial decrease in functional status on all 6 SF-20 subscales. Also, symptom-related difficulty, sick days, and health care utilization increased.
Patient Alerts has developed a GAD7 Screening Tool to be used in a Clinical System.
GAD-7 is a sensitive self-administrated test to assess generalized anxiety disorder,normally used in outpatient and primary care settings for referral to psychiatrist pending outcome.
GAD-7 is a self-reported questionnaire for screening and severity measuring of generalized anxiety disorder (GAD).
